Key Highlights

  • CDT Equity (NASDAQ:CDT) traded at USD 0.0493 intraday on November 4, 2026, down 26.42%, on about 3.54 million shares with a market Capitalization near USD 459.61 thousand.
  • An 8-K signed November 4, 2026 reports a 1-for-20 reverse split effective November 5 at 5:00 p.m. ET, with split-adjusted trading starting November 6 at market open.
  • The split cuts shares outstanding from 20,357,283 to about 1,017,864, and follows a 1-for-25 split that took effect September 28, 2026.
  • A prospectus supplement dated November 4, 2026 covers resale of 673,023 shares by selling holders, and the company receives no proceeds from those sales.

What Moved CDT Equity During Trading (down USD 0.0177, 26.42%)

CDT Equity (NASDAQ:CDT) traded at USD 0.0493 during regular hours on November 4, 2026, which is 26.42% lower. The implied prior close is USD 0.0670 (calculated as USD 0.0493 divided by 0.7358), so the drop is about USD 0.0177 per share. A prospectus supplement filed the same day lists a last reported price of USD 0.067 on November 3, 2026, which matches that calculation. Intraday data showed about 3.54 million shares traded and a relative Volume of 0.12, meaning turnover was well below the usual pace. A low-volume decline of this size on a stock with a market capitalization near USD 459.61 thousand shows how little trading it takes to move the quote.

The Reverse Split Filing Behind the Headlines

The 8-K reports that a certificate of amendment was filed on November 2, 2026 and that the report was signed on November 4, 2026. A 1-for-20 reverse split takes effect at 5:00 p.m. ET on November 5, 2026, and split-adjusted trading begins on November 6, 2026 at market open under the same CDT symbol with a new CUSIP, 20678X809. Shares outstanding fall from 20,357,283 to about 1,017,864, and fractions are paid in cash. A reverse split does not change what a holder owns as a share of the company, because the price per share rises while the share count falls, and it is meant to keep the bid above the Nasdaq minimum. Stockholders earlier approved future splits and left the timing to the board.

Prior Split, Resale Supply and Trading Risks

This is the second reverse split in about six weeks. A 1-for-25 split took effect on September 28, 2026 and cut shares outstanding to about 1,013,515, according to the company release. Since then the count has grown to 20,357,283, so the quote has fallen from the post-split level to a few cents. CDT Equity is a biopharmaceutical company, formerly Conduit Pharmaceuticals, based in Naples, Florida. The prospectus supplement registers 673,023 resale shares, including 140,925 issuable on conversion of senior secured convertible notes. Conversion and resale can add supply. In a micro cap with a small number of trades, spreads can be wide and quoted moves can reverse, so the decline should not be read as a trend.

Where Things Stand

CDT Equity (NASDAQ:CDT) is down 26.42% intraday on November 4, 2026, and the filings point to dilution pressure around a second reverse split in six weeks rather than a clinical or Earnings event. No pipeline news dated November 2 to November 4 was identified. The reverse split takes effect November 5, so the quoted price will jump mechanically on November 6 without changing a holder's proportional ownership. Investors should watch whether the price holds above the Nasdaq minimum after the split, how many shares are issued through note conversions, and whether the company discloses financing terms.